Personalized heart pill aims to stop second heart attacks
Disease control
Recruiting now
This study tests whether the drug dalcetrapib can prevent future heart attacks and strokes in people who recently had a heart-related hospitalization. It enrolls 2,000 participants with a specific genetic profile (AA genotype) who are clinically stable after their recent cardiac …
Phase: PHASE3 • Sponsor: DalCor Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC